Navigation Links
Dr. Reddy's To Launch 'Polypill' For Treating Heart Disease

Indian pharma major Dr. Reddy's Laboratories will launch a first-of-its-kind pill to tackle heart diseases in the second half of 2007, it was announced Thursday. //

The company has teamed up with researchers at University of Auckland, New Zealand, for trials of the groundbreaking 'polypill' that combines four medicines including aspirin and statin, commonly used to treat heart ailments.

India records nearly 2.8 million deaths a year due to cardio-vascular diseases.

'Trials in India are underway. We are conducting trials on 220 patients and after testing on 440 more cases, the product will be launched in the Indian market,' said Satish Reddy, managing director of Dr. Reddy's Lab.

'We have already received the necessary approval from the government for conducting the trails. We hope the product will be available to masses in the second quarter of 2007,' he told reporters at the New Zealand High Commission here.

'This is first-of-its-kind drug in the world to tackle heart problem and will open newer vistas to handle such ailments,' Reddy told IANS, adding it will cost Rs.100 for 30 tablets.

New Zealand's High Commissioner to India Graeme Waters said: 'This project holds open the possibility of revolutionising an important aspect of healthcare in both developing and developed countries.'

The new drug will be cheaper to administer and more effective in preventing strokes and heart attacks, said Anthony Rodgers, a researcher at Auckland University.

The trial aims to confirm that the polypill is effective in lowering cholesterol and blood pressure - known causes of heart attacks and strokes.

The Health Research Council of New Zealand invested NZ$350,000 to support the overall co-ordination of the trial and recruitment in New Zealand. Dr. Reddy's will invest NZ$ 7.5 million in developing the polypill and providing supplies for clinical trials globally.

Source- IANS
'"/>




Related medicine news :

1. AAI Pharma Files Lawsuit Against Dr. Reddys Laboratories
2. Dr Reddys Launches Generic Version Of Mercks Proscar Tablets
3. Dr. Reddys To Invest $100 Mn In Andhra
4. Dr Reddys Eyeing for Generics Arm of Merck
5. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
6. Nutrient Profiling System Launched By Food Officials in UK
7. New Oat And Soy-Based Fat Replacer Launched
8. Launch Of India’s First Virology Course At Pun
9. Race Based Genome Project Launched By Mexico
10. Bird flu In Indonesia: Government To Launch ‘Village Preparedness’ Schee
11. Action Plan Against Drug Deaths Launched
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/19/2017)... IL (PRWEB) , ... January 19, 2017 , ... ... N.A., announced it recently provided a new $11,250,000 senior credit facility to Sunrise, ... new MB credit facility were used to facilitate a recapitalization of MedPro led ...
(Date:1/19/2017)... Huntington Beach, CA (PRWEB) , ... January 19, ... ... for Oral Health, is now offering treatments for patients with sleep apnea and ... far-reaching consequences for dental and physical health. Dr. Rassouli provides personalized care to ...
(Date:1/19/2017)... , ... January 19, 2017 , ... Sam & Associates ... to commercial and residential clients in the California Bay Area, is launching a charity ... in the region. , Heart disease is the primary killer of adult men and ...
(Date:1/19/2017)... ... ... St. Catherine’s Village announced that a limited number of rooms have become available ... grounds of the St. Catherine’s Village campus in Madison, Mississippi that accommodates 120 residents ... Mississippi for the second year in a row by readers of the Clarion-Ledger. , ...
(Date:1/19/2017)... ... January 18, 2017 , ... The CHP suggests that California ... rain storm by slowing down and increasing the space between themselves and other vehicles, ... based car accident attorney Raymond R. Hassanlou notes that, rain or shine, drivers should ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... January 19, 2017 The global  pacemaker market  is expected ... Grand View Research, Inc. The heightening prevalence of cardiac conditions coupled with the ... Pacemaker globally. In addition, technological enhancements in these devices are supporting the expansion ... ... Grand View Research Logo ...
(Date:1/19/2017)... , Jan. 18, 2017   Synthetic Biologics, ... company developing therapeutics designed to preserve the microbiome ... today confirmed plans to initiate a Phase 2b/3 ... reformulation of lovastatin lactone designed to reduce methane ... in the gut to treat the underlying cause ...
(Date:1/18/2017)... -- Aprima Medical Software, a leading provider of innovative ... revenue cycle management (RCM) solutions for medical practices, ... Healthcare Data Solutions (HDS) of Coral Cables, FL. ... full support for HDS,s customers, which include approximately ... states. Financial terms were not disclosed. ...
Breaking Medicine Technology: